| ANRO Stock | | | 2.65 0.04 1.49% |
This module uses fundamental data of Alto Neuroscience, to approximate its Piotroski F score. Alto Neuroscience, F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Alto Neuroscience,. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Alto Neuroscience, financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Alto Neuroscience, Altman Z Score,
Alto Neuroscience, Correlation,
Alto Neuroscience, Valuation, as well as analyze
Alto Neuroscience, Alpha and Beta and
Alto Neuroscience, Hype Analysis.
To learn how to invest in Alto Stock, please use our
How to Invest in Alto Neuroscience, guide.
At this time, Alto Neuroscience,'s
Short Term Debt is very stable compared to the past year. As of the 23rd of March 2025,
Net Debt To EBITDA is likely to grow to 2.51, while
Short and Long Term Debt Total is likely to drop about 3.9
M. At this time, Alto Neuroscience,'s
EV To Operating Cash Flow is very stable compared to the past year. As of the 23rd of March 2025,
EV To Free Cash Flow is likely to grow to 1.27, though
Free Cash Flow Yield is likely to grow to
(0.45).
At this time, it appears that Alto Neuroscience,'s Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Lower Leverage| Focus | |
| Change In Outstending Shares | |
Alto Neuroscience, Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Alto Neuroscience, is to make sure Alto is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Alto Neuroscience,'s auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Alto Neuroscience,'s financial numbers are properly reported.
Alto Neuroscience, F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Alto Neuroscience,'s different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Alto Neuroscience, in a much-optimized way.
Click cells to compare fundamentals
About Alto Neuroscience, Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Alto Neuroscience, ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alto Neuroscience,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alto Neuroscience,'s managers, analysts, and investors.
About Alto Neuroscience, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alto Neuroscience,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alto Neuroscience, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Alto Neuroscience, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Pair Trading with Alto Neuroscience,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Alto Neuroscience, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience, to buy it.
The correlation of Alto Neuroscience, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
When determining whether Alto Neuroscience,
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alto Neuroscience,'s
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alto Neuroscience, Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Alto Neuroscience, Stock: Check out
Alto Neuroscience, Altman Z Score,
Alto Neuroscience, Correlation,
Alto Neuroscience, Valuation, as well as analyze
Alto Neuroscience, Alpha and Beta and
Alto Neuroscience, Hype Analysis.
To learn how to invest in Alto Stock, please use our
How to Invest in Alto Neuroscience, guide.
You can also try the
Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets | Return On Equity |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine
if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.